Literature DB >> 12084397

Protective effects of estrogen on the cardiovascular system.

Michael E Mendelsohn1.   

Abstract

Estrogen has direct and indirect effects on the cardiovascular system that are mediated by the estrogen receptors ER-alpha and ER-beta. The direct effects of estrogen occur through rapid nongenomic and longer-term genomic pathways. The rapid effects of estrogen are mediated by ERs and result in the activation of endothelial nitric oxide synthase, leading to arterial vasodilation. Longer-term effects involve changes in gene and protein expression, modulating the response to injury and atherosclerosis. Estrogen also indirectly influences serum lipoprotein and triglyceride profiles, and the expression of coagulant and fibrinolytic proteins. Advanced atherosclerosis and certain progestins, however, may attenuate some of the protective effects of estrogen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084397     DOI: 10.1016/s0002-9149(02)02405-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  89 in total

Review 1.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

2.  Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12).

Authors:  Darlene C Deecher; Pamela Swiggard; Donald E Frail; Lawrence T O'Connor
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

3.  Incarcerating death: mortality in U.S. state correctional facilities, 1985-1998.

Authors:  Evelyn J Patterson
Journal:  Demography       Date:  2010-08

4.  The impact of gender on cardiovascular system calcification in very elderly patients with severe aortic stenosis.

Authors:  Luckmini Liyanage; Nam Ju Lee; Tessa Cook; Howard C Herrmann; Dinesh Jagasia; Harold Litt; Yuchi Han
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-29       Impact factor: 2.357

5.  Identification and structure-activity relationships of a novel series of estrogen receptor ligands based on 7-thiabicyclo[2.2.1]hept-2-ene-7-oxide.

Authors:  Pengcheng Wang; Jian Min; Jerome C Nwachukwu; Valerie Cavett; Kathryn E Carlson; Pu Guo; Manghong Zhu; Yangfan Zheng; Chune Dong; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  J Med Chem       Date:  2012-02-21       Impact factor: 7.446

Review 6.  Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.

Authors:  Morris Notelovitz
Journal:  MedGenMed       Date:  2006-03-28

7.  Irreversible Primary Amenorrhea Secondary to Uterine Damage and Premature Ovarian Failure in 2 Patients with Ewing Sarcoma.

Authors:  Angeliki Makri; Alison M Boyce; Constantine A Stratakis; Maya Lodish
Journal:  J Pediatr Adolesc Gynecol       Date:  2018-05-29       Impact factor: 1.814

8.  Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause.

Authors:  Samar R El Khoudary; Nanette Santoro; Hsiang-Yu Chen; Ping G Tepper; Maria M Brooks; Rebecca C Thurston; Imke Janssen; Sioban D Harlow; Emma Barinas-Mitchell; Faith Selzer; Carol A Derby; Elizabeth A Jackson; Daniel McConnell; Karen A Matthews
Journal:  Eur J Prev Cardiol       Date:  2015-09-18       Impact factor: 7.804

9.  Women and men with coronary heart disease in three countries: are they treated differently?

Authors:  Markus Bönte; Olaf von dem Knesebeck; Johannes Siegrist; Lisa Marceau; Carol Link; Sara Arber; Ann Adams; John B McKinlay
Journal:  Womens Health Issues       Date:  2008 May-Jun

10.  Differential effects of estradiol on carotid artery inflammation when administered early versus late after surgical menopause.

Authors:  Areepan Sophonsritsuk; Susan E Appt; Thomas B Clarkson; Carol A Shively; Mark A Espeland; Thomas C Register
Journal:  Menopause       Date:  2013-05       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.